Sotera Health (SHC) Cash from Financing Activities (2020 - 2026)
Sotera Health (SHC) posted quarterly Cash from Financing Activities of -$12.8 million for Q1 2026, down 58.02% year-over-year from -$30.4 million in Q1 2025, and down 56.32% on a QoQ basis from -$8.2 million in Q4 2025.
Sotera Health (SHC) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Sotera Health (SHC) has reported Cash from Financing Activities for 7 consecutive years, with -$12.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 58.02% year-over-year to -$12.8 million; the TTM figure through Mar 2026 stood at -$105.2 million (down 125.28% YoY), while the FY2025 annual figure was -$100.5 million, down 98.83% from the prior year.
- Cash from Financing Activities came in at -$12.8 million for Q1 2026 at Sotera Health, down from -$8.2 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $273.9 million in Q1 2023, with the low at -$77.3 million in Q3 2025.
- Average Cash from Financing Activities over 5 years is $17.6 million, with a median of -$3.8 million recorded in 2023.
- Across the five-year window, Cash from Financing Activities soared 61105.79% in 2023 and plunged 4043.8% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at $199.2 million in 2022, then plunged by 101.9% to -$3.8 million in 2023, then sank by 72.63% to -$6.5 million in 2024, then decreased by 24.85% to -$8.2 million in 2025, then slumped by 56.32% to -$12.8 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$12.8 million, -$8.2 million, and -$77.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Sotera Health | 5.06 Bn | 4.74 Bn | 147.07 Mn | -12.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.78 Mn |
| Mar 31, 2026 | -12.78 Mn |
| Dec 31, 2025 | -8.18 Mn |
| Dec 31, 2025 | -8.18 Mn |
| Sep 30, 2025 | -77.34 Mn |
| Sep 30, 2025 | -77.34 Mn |
| Jun 30, 2025 | -6.93 Mn |
| Jun 30, 2025 | -6.93 Mn |
| Mar 31, 2025 | -8.09 Mn |
| Mar 31, 2025 | -8.09 Mn |
| Dec 31, 2024 | -6.55 Mn |
| Dec 31, 2024 | -6.55 Mn |
| Sep 30, 2024 | -2.65 Mn |
| Sep 30, 2024 | -2.65 Mn |
| Jun 30, 2024 | -29.42 Mn |
| Jun 30, 2024 | -29.42 Mn |
| Mar 31, 2024 | -11.94 Mn |
| Mar 31, 2024 | -11.94 Mn |
| Dec 31, 2023 | -3.79 Mn |
| Dec 31, 2023 | -3.79 Mn |